Wound healing in cancer patients under immunotherapy
Open Access
- 27 June 2025
- journal article
- review article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (10) , 7087-7098
Abstract
This comprehensive review examines the impact of cancer immunotherapies on wound healing, focusing on recent clinical evidence. While most cancer patients on immunotherapy heal surgical and accidental wounds without significant impairment, immune system alterations can sometimes delay healing or cause unique wound pathologies. Neoadjuvant immunotherapy before complex surgeries has shown higher wound complication rates in some cohorts, suggesting careful patient selection is needed. Immune checkpoint inhibitors don’t typically increase general surgical complication rates, offering reassurance for most procedures. However, immunotherapy can directly cause wounds through immune-related adverse events like bullous pemphigoid or pyoderma gangrenosum, requiring specialized management. For malignant wounds, immunotherapy offers potential benefits by treating the underlying cancer. Management strategies include preoperative planning, careful surgical technique, close postoperative monitoring, and multidisciplinary collaboration. Despite adding complexity to wound healing, immunotherapy’s cancer control benefits typically outweigh risks. With appropriate strategies and vigilance for impaired healing or unusual wound presentations, most patients can undergo surgery safely while continuing immunotherapy. Further research is needed to develop evidence-based guidelines for perioperative immunotherapy management.Keywords
This publication has 91 references indexed in Scilit:
- Cancer-Stimulated Mesenchymal Stem Cells Create a Carcinoma Stem Cell Niche via Prostaglandin E2 SignalingCancer Discovery, 2012
- Mast Cells and Wound HealingAdvances in Wound Care, 2012
- Structure Fires, Smoke Production, and Smoke AlarmsJournal of Burn Care & Research, 2011
- Regenerative Therapy After Cancer: What Are the Risks?Tissue Engineering Part B: Reviews, 2010
- Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient careThe Lancet Oncology, 2010
- A Review on Bevacizumab and Surgical Wound HealingAnnals of Plastic Surgery, 2009
- Wound Healing in PatientsWith Cancer2008
- Wound healing effect of adipose-derived stem cells: A critical role of secretory factors on human dermal fibroblastsJournal of Dermatological Science, 2007
- Autologous Bone Marrow–Derived Cultured Mesenchymal Stem Cells Delivered in a Fibrin Spray Accelerate Healing in Murine and Human Cutaneous WoundsTissue Engineering, 2007
- Radiotherapy and wound healingInternational Wound Journal, 2005